HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
HLA types, especially HLA-DR3, are associated with the development of toxic reactions in patients with rheumatoid arthritis after treatment with gold or D-penicillamine. In this study, after treatment with sulphasalazine, leucopenia was observed in three patients, who all had a history of leucopenia...
Salvato in:
| Pubblicato in: | Ann Rheum Dis |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
1989
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003812/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2570550/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.48.7.539 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
